For those of us who have practiced radiology for more than 10 years, the rapid increase in the volume of our chest computed tomography (CT) business has been truly extraordinary. When I arrived at the University of Maryland as a neophyte attending thoracic radiologist in 1991, we would routinely pass our days contemplating the diagnoses of perhaps 2 or 3 chest CT scans. Fast-forwarding to 2006, we typically interpret 40 or more CT studies at a much less leisurely pace.
Dr. White
is the Director of Thoracic Imaging, Diagnostic Imaging
Department, University of Maryland Medical Center, Baltimore,
MD.He is also a member of the editorial board of this
journal.
For those of us who have practiced radiology for more than 10
years, the rapid increase in the volume of our chest computed
tomography (CT) business has been truly extraordinary. When I
arrived at the University of Maryland as a neophyte attending
thoracic radiologist in 1991, we would routinely pass our days
contemplating the diagnoses of perhaps 2 or 3 chest CT scans.
Fast-forwarding to 2006, we typically interpret 40 or more CT
studies at a much less leisurely pace.
This remarkable increase in chest CT volume has been facilitated
by rapidly advancing technological capabilities, such as
multidetector CT, and the attendant expansion of indications for
pulmonary CT. For example, high-resolution CT was in its infancy in
1991; now, it is considered a standard part of the CT
armamentarium. Perhaps the largest contributor to the increased
volume of studies has been the use of chest CT to evaluate patients
with suspected pulmonary embolism. This indication did not exist in
1991, but it now accounts for approximately 20% of our total CT
volume.
This flood of CT studies naturally raises the question of
whether clinicians have come to rely too heavily on the "truth"
provided by CT images. Those who decry CT overutilization suggest
that the art of history taking and physical diagnosis is being cast
aside in favor of objective data whose value may be overrated. Even
"simpler" imaging technology is often abandoned. Today, many
patients with suspected pulmonary embolism proceed directly to CT
without even undergoing a chest radiograph.
In actuality, both defenders and critics of the current level of
CT utilization are probably oversimplifying a highly nuanced set of
circumstances. Critics correctly point to the arbitrary nature of
many of the clinical requests for chest CT, some of which are often
motivated by medicolegal considerations. Defenders recognize that
greater experience can lead to improved diagnostic acumen. The
reality is, however, that radiologists are hesitant to serve as
utilization gatekeepers for fear of alienating referring
clinicians.
Ultimately, we must rely on rigorous scientific inquiry to
determine the proper use of pulmonary CT scanning. Too often,
imaging decisions are made on an empiric basis. The current debate
on overutilization of CT in general, and chest CT in particular,
speaks strongly to the need for well-designed outcomes research to
define the appropriate uses for our increasingly powerful
technologies. Prospective studies in large patient populations are
needed to determine appropriate imaging strategies-considering risk
factors, laboratory studies, and clinical signs and symptoms-that
can guide rational use of this technology to optimize accuracy of
diagnosis, limit costs and radiation exposure, and minimize the
potential for medicolegal actions.